Sectors
PMN
ProMIS Neurosciences, Inc.
13.91
5 x 13.72
1 x 15.72
bid
ask
-
0.58
4.00%
10:02 AM
timesize
| Ytd | 103.66% | |
| 1y | -32.15% |
14.44
day range
14.44
6.76
52 week range
24.79
| Open | 14.44 | Prev Close | 14.49 | Low | 14.44 | High | 14.44 | Mkt Cap | 18.95M |
| Vol | 6.45K | Avg Vol | 48.60K | EPS | -11.66 | P/E | -1.24 | Forward P/E | -1.51 |
| Beta | -0.23 | Short Ratio | 2.64 | Inst. Own | 50.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 11.41 | 200-d Avg | 11.95 | 1yr Est | 7.65 |
PMN News
benzinga.com
ProMIS Neurosciences' PMN310 Shows Dose-Dependent Reduction Of Amyloid-Beta Oligomers In Healthy Vol
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid
benzinga.com
Roth Capital Initiates Coverage On ProMIS Neurosciences with Buy Rating, Announces Price Target of $
Roth Capital analyst Boobalan Pachaiyappan initiates coverage on ProMIS Neurosciences (NASDAQ:PMN
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
benzinga.com
Cantor Fitzgerald Initiates Coverage On ProMIS Neurosciences with Overweight Rating
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ:PM
benzinga.com
HC Wainwright & Co. Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ProMIS Neurosciences (NASDAQ:PMN) w
benzinga.com
Earnings Scheduled For May 12, 2026
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for tra
benzinga.com
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Fri
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo